"Transcatheter aortic valve replacement"

SCAI Expert Consensus Statement on Alternative Access for Transcatheter Aortic Valve Replacement www.jscai.org Verify you are human by completing the action below. www.jscai.org needs to review the security of your connection before proceeding.Ray ID: 921cb278f9f64130Performance & security by Cloudflare

Preprocedural Planning for Transcatheter Aortic Valve Replacement Revised 2023 ACR Appropriateness Criteria® 1 Transcatheter Aortic Valve Replacement American College of Radiology ACR Appropriateness Criteria®Preprocedural Planning for Transcatheter Aortic Valve Replacement Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial contrast Usually Not Appropriate O CT chest with IV contrast Usually Not Appropriate ☢☢☢CT chest without and with IV contrast Usually Not Appropriate ☢☢☢CT chest without IV contrast Usually Not Appropriate ☢☢☢ACR Appropriateness Criteria® 2 Transcatheter Aortic Valve Replacement Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular

Preprocedural Planning for Transcatheter Aortic Valve Replacement Revised 2023 ACR Appropriateness Criteria® 1 Transcatheter Aortic Valve Replacement American College of Radiology ACR Appropriateness Criteria®Preprocedural Planning for Transcatheter Aortic Valve Replacement Variant 1: Preintervention planning for transcatheter aortic valve replacement: assessment of aortic root. Initial contrast Usually Not Appropriate O CT chest with IV contrast Usually Not Appropriate ☢☢☢CT chest without and with IV contrast Usually Not Appropriate ☢☢☢CT chest without IV contrast Usually Not Appropriate ☢☢☢ACR Appropriateness Criteria® 2 Transcatheter Aortic Valve Replacement Variant 2: Preintervention planning for transcatheter aortic valve replacement: assessment of supravalvular

Home-Based Rehabilitation After Transcatheter Aortic Valve Replacement (REHAB-TAVR): A Pilot Randomized Controlled Trial The benefit of early cardiac rehabilitation after transcatheter aortic valve replacement (TAVR) is not well established. This pilot study evaluated the feasibility and short-term effects of a home-based exercise program, with or without cognitive-behavioral intervention (CBI

Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD Neurohormonal modulation and afterload reduction are key for treatment of heart failure with reduced ejection fraction (HFrEF). In HFrEF patients with concomitant moderate aortic stenosis (AS), treatment with transcatheter aortic valve replacement (TAVR) may be complementary

Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis. For patients with asymptomatic severe aortic stenosis and preserved left ventricular ejection fraction, current guidelines recommend routine clinical surveillance every 6 to 12 months. Data from randomized trials examining whether early intervention with transcatheter aortic-valve replacement (TAVR) will improve

Transcatheter Aortic Valve Replacement for Aortic Valve Stenosis Case Report. This case report details the interdisciplinary care provided to a 48-year-old male patient with severe aortic valve stenosis who underwent transcatheter aortic valve replacement in a community hospital setting. Focus is placed on the interdisciplinary team model demonstrated in the care of this patient, including

Hemodynamic Valve Deterioration After Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Clinical Outcomes. Reports on the durability of transcatheter aortic valve replacement (TAVR) prostheses are scarce and confounded by varying definitions and competing risks of death. The authors sought to determine the incidence, predictors, and clinical outcomes of hemodynamic valve

Surgical Bailout in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Incidence, Trends, and Clinical Outcomes. Transcatheter aortic valve replacement (TAVR) harbors the risk of periprocedural complications that require emergent cardiac surgery, or "surgical bailout." Surgical bailout intends to be lifesaving but is associated with high mortality. This has given rise

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison. Heavy calcifications in severe aortic stenosis (AS) pose a major challenge in patients undergoing transcatheter aortic valve replacement (TAVR). Only a few studies have addressed the performance of different transcatheter heart valves (THV) in this subgroup of patients. We aimed

Predictors of Outcomes of Reintervention After Transcatheter Aortic Valve Replacement: FRANCE 2 and FRANCE TAVI Registries. In a context of extending transcatheter aortic valve replacement (TAVR) to patients with a longer life expectancy, it is important to better document the incidence and outcomes of reintervention. The authors sought to evaluate the incidence, predictive factors, and long

Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art Review. Transcatheter aortic valve replacement (TAVR) has become the preferred treatment option in appropriate patients with symptomatic severe aortic stenosis (AS). A number of advancements have since expanded the eligible population to bicuspid aortic valve with feasible anatomy; small aortic annuli; low

Dual ProGlide vs ProGlide and Angio-Seal for Femoral Access Hemostasis After Transcatheter Aortic Valve Replacement: A Randomised Comparative Trial. Vascular complications increase morbidity and mortality after transcatheter aortic valve replacements (TAVR), often related to failures in vascular closure devices (VCDs). We intended to compare the dual Perclose ProGlide (PP) strategy

Clinical Outcomes of Direct Oral Anticoagulant Versus Warfarin After Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry. Transcatheter aortic valve replacement (TAVR) recipients frequently have an indication for long-term oral anticoagulation, including atrial fibrillation or systemic thromboembolic disease. It remains unclear if there are differences in safety

Surgical versus Transcatheter Aortic Valve Replacement in Patients 65 Years of Age and Older. Approval of transcatheter aortic valve replacement (TAVR) for all risk profiles has extended TAVR use in patients not otherwise examined in clinical trials. We sought to evaluate contemporary real-world outcomes of surgical aortic valve replacement (SAVR) vs TAVR in Medicare beneficiaries by risk strata

Impact of hypotonic hyponatremia on outcomes in patients undergoing transcatheter aortic valve replacement: a national inpatient sample. Transcatheter aortic valve replacement (TAVR) has emerged as a major therapeutic option for treating aortic stenosis. Hyponatremia is a common electrolyte disorder closely associated with adverse cardiovascular outcomes. However, large-scale studies

Redo Surgical Aortic Valve Replacement versus Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprosthetic Valves. Valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) is associated with improved perioperative safety compared to redo surgical aortic valve replacement (redo-SAVR), but long-term outcomes remain uncertain. We therefore compare long-term outcomes

Implementing a Nurse-Driven Early Ambulation Protocol to Enhance Post-Transcatheter Aortic Valve Replacement Outcomes: A Quality Improvement Initiative. Immobility in patients undergoing transcatheter aortic valve replacement (TAVR) is linked to adverse outcomes and prolonged length of stay (LOS). Advancements in TAVR procedures allow for early ambulation post-procedure. In a large teaching

Outcomes and Predictors of Different Flow-Gradient Patterns of Aortic Stenosis Following Transcatheter Aortic Valve Replacement. This study sought to explore the clinical factors associated with classical low-flow low-gradient (C-LFLG) and normal-flow low-gradient (NFLG) aortic stenosis (AS) compared to high-gradient (HG) AS. We also compared clinical and echocardiographic outcomes after transcatheter aortic valve replacement (TAVR) across flow-gradient patterns. Patients with C-LFLG AS have a higher mortality rate after TAVR than those with HG AS. However, what leads to C-LFLG AS and the predictors of mortality in this population remain unclear. In this retrospective, single-center study involving 1415 patients with severe AS, patients were classified into: 1) HG: (aortic valve mean gradient

Incidence, Predictors, and Outcomes of Unplanned Coronary Angiography After Transcatheter Aortic Valve Replacement. Assessment of coronary artery disease (CAD) is critical in managing severe aortic stenosis. Unplanned coronary angiography after TAVR, with or without percutaneous coronary intervention, may present significant challenges. The aim of this study was to evaluate the incidence , predictors, and outcomes of unplanned coronary angiography after transcatheter aortic valve replacement (TAVR). All TAVR procedures between July 2015 and December 2021 were examined for the occurrence of unplanned angiography and for procedural success with percutaneous coronary intervention if attempted, and a machine learning prediction model was created. Among 1,444 patients (median age 81 years, 59